Telma Beta 50 mg Tablet

• Manage high blood pressure

Telma Beta 50mg tablet cause common side effects just like any other medication should. Consult the healthcare professional to avoid further complications during the treatment. Common ones include:

• Fatigue (tiredness)
• Bradycardia
• Gastrointestinal disturbance
• Electrolyte imbalance
• The increased glucose level in the blood
• Postural hypotension
• Angioedema and urticaria
• Visual disturbance
• Breathlessness
• Muscle cramp

• Headache
• Dizziness
• Sleepiness
• Ankle swelling

• Telma Beta 50mg tablet always be taken under doctor guidance to ensure safety and effectiveness of the medication. Do not overdose or skip the medication to make up for the missed one without consultation with a healthcare professional.
• The tablet is taken with or without food at the fixed time everyday to maintain consistent blood level.
  
  

• Telma Beta 50mg tablet is a prescription based medication. It contains two active ingredient Telmisartan in (40mg) concentration that relaxes and widens blood vessels by blocking angiotensin II, helping blood flow more easily and lowering the blood pressure.
• Metoprolol Succinate in (50mg), slows the heart rate and reduces the force of heart contractions, lowering blood pressure and reducing strain on the heart. They both work together to manage the high blood pressure.
  
  

• Lacourciére, Y., & Martin, K. (2002). Comparison of a fixed-dose combination of 40 mg telmisartan plus 12.5 mg hydrochlorothiazide with 40 mg telmisartan in the control of mild to moderate hypertension. American journal of therapeutics, 9(2), 111-117. https://pubmed.ncbi.nlm.nih.gov/11897925/
• Chen, J. H., Cheng, J. J., Chen, C. Y., Chiou, H. C., Huang, T. Y., Tsai, C. D., ... & Cherng, W. J. (2004). Comparison of the efficacy and tolerability of telmisartan 40 mg vs. enalapril 10 mg in the treatment of mild‐to‐moderate hypertension: a multicentre, double‐blind study in Taiwanese patients. International Journal of Clinical Practice, 58, 29-34. https://pubmed.ncbi.nlm.nih.gov/15617456/
• McGill, J. B., & Reilly, P. A. (2001). Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial. Clinical therapeutics, 23(6), 833-850. https://pubmed.ncbi.nlm.nih.gov/11440284/
• Wikstrand, J., Andersson, B., Kendall, M. J., Stanbrook, H., & Klibaner, M. (2003). Pharmacokinetic considerations of formulation: extended-release metoprolol succinate in the treatment of heart failure. Journal of cardiovascular pharmacology, 41(2), 151-157. https://pubmed.ncbi.nlm.nih.gov/12548073/
• Papadopoulos, D. P., & Papademetriou, V. (2009). Metoprolol succinate combination in the treatment of hypertension. Angiology, 60(5), 608-613. https://pubmed.ncbi.nlm.nih.gov/19033265/